Dergiler / Eurasian Journal of Medicine and Oncology / 2021 / Cilt: 5 - Sayı: 1

Multisystemic Long-Term Sequelae of Covid-19: A ReviewBased on the Current Literature Over a Year of PandemicExperience

Sayfa
6–19
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In the report, long-term pulmonary sequels andsystemic problems including cardiovascular, neurological, psychiatric, endocrinologic, nephrological, hematologic,gastrointestinal, dermatologic, etc. of COVID-19 are discussed in accordance with recent scientific publications.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:On January 7, 2020, it was announced that the Chinese Government isolated a new variant of Coronavirus (SARSCoV-2).
📊
Temel Bulgular & Veri:As of 28 December 2020, 81,000,000 cases have been confirmed globally, and approximately 1,770,000total deaths have been reported for COVID-19.
💡
Sonuç & Katkı:In the report, long-term pulmonary sequels andsystemic problems including cardiovascular, neurological, psychiatric, endocrinologic, nephrological, hematologic,gastrointestinal, dermatologic, etc. of COVID-19 are discussed in accordance with recent scientific publications.
🔬Tür:Araştırma Makalesi
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

On January 7, 2020, it was announced that the Chinese Government isolated a new variant of Coronavirus (SARSCoV-2). Officials reported that populations were not equally affected in terms of the number of cases, severe illness,and death. As of 28 December 2020, 81,000,000 cases have been confirmed globally, and approximately 1,770,000total deaths have been reported for COVID-19. Besides difficulties of COVID-19 management in the acute stage,long-term consequences of the infection could cause widespread public health problems across the World. This re view article aims to examine current literature regarding COVID-19, identify post-illness sequelae, detect patients atrisk for sequelae, and provide guidance to management strategies. In the report, long-term pulmonary sequels andsystemic problems including cardiovascular, neurological, psychiatric, endocrinologic, nephrological, hematologic,gastrointestinal, dermatologic, etc. of COVID-19 are discussed in accordance with recent scientific publications.

🔖

Bu Makaleye Atıf Yap

ATEŞ, S., ÖZPAK, L., BÜYÜKŞİMŞEK, M., AKSU, E., ŞAHİN, A. R., KOÇYİĞİT, B. F., OKYAY, R. A., SÜMBÜL, H. E., TAŞDOĞAN, A. M., MEŞEN, A., DEMİRKOL, M. K., BEYOĞLU, A., ACIPAYAM, A., ŞAHİN, M., ŞENEL, M. E., GÜLÜMSEK, E., TURGUT, C. (2022). Multisystemic Long-Term Sequelae of Covid-19: A ReviewBased on the Current Literature Over a Year of PandemicExperience. Eurasian Journal of Medicine and Oncology, Cilt: 5 - Sayı: 1, 6–19. https://ajindex.com/articles/509480

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song Jet al
  2. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020
  3. 727–33. [CrossRef] 2. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA 2020
  4. 1775–6. [CrossRef] 3. Kumar A, Gupta PK, Srivastava A. A review of modern technologies for tackling COVID-19 pandemic. Diabetes Metab Syndr 2020
  5. 569–73. [CrossRef] 4. Tang YW, Schmitz JE, Persing DH, Stratton CW. Laboratory Diagnosis of COVID-19: Current Issues and Challenges. J Clin Microbiol 2020
  6. e00512–20. [CrossRef] 5. Ihle-Hansen H, Berge T, Tveita A, Rønning EJ, Ernø PE, Andersen EL, et al. COVID-19: Symptoms, course of illness and use of clinical scoring systems for the first 42 patients admitted to a Norwegian local hospital. Tidsskr Nor Laegeforen 2020
  7. Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD) Division of Viral Diseases. Symptoms of Coronavirus. Available at: https://www.cdc.gov/coronavirus/2019-ncov/symptomstesting/symptoms.html. Accessed Dec 28, 2020. 7. Wordlometers, Coronavirus. Available at: https://www.worldometers.info/coronavirus/. Accessed Dec 28, 2020. 8. Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect 2020
  8. 607–13. [CrossRef] 9. Li G, He X, Zhang L, Ran Q, Wang J, Xiong A, et al. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19. J Autoimmun 2020
  9. 102463. [CrossRef] 10. WHO. 2019- nCoV Situation Report-1 on 21 January, 2020. Available at: https://www.who.int/emergencies/diseases/ novel-coronavirus-2019/situation-reports/. Accessed Jan 21, 2020. 11. Hui DS, Wong KT, Ko FW, Tam LS, Chan DP, Woo J, et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest 2005
  10. 2247–61. [CrossRef] 12. Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax 2005
  11. 401–9. [CrossRef] 13. Antonio GE, Wong KT, Hui DS, Wu A, Lee N, Yuen EH, et al. Thinsection CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology 2003